Table 2.
Optimal flow of Tetracycline to pharmacies (t = 1, 2, 3)
| Brand | Pharmacy | No competition | Competitive market | ||||
|---|---|---|---|---|---|---|---|
| Product flow in each period | Product flow in each period | ||||||
| 1 | 2 | 3 | 1 | 2 | 3 | ||
| Plavix | 1 | 540 | 700 | – | 845 | 1115 | – |
| 2 | 400 | 510 | – | 535 | 640 | – | |
| 3 | 900 | 910 | – | 900 | 955 | – | |
| 4 | 350 | 300 | 310 | 200 | 185 | 175 | |
| 5 | 290 | 300 | 295 | 175 | 184 | 184 | |
| 6 | 210 | 210 | 210 | 180 | 185 | 180 | |
| 7 | 350 | 450 | 284 | 480 | 614 | 400 | |
| Osvah | 1 | 530 | 800 | – | 225 | 385 | – |
| 2 | 400 | 510 | – | 264 | 380 | – | |
| 3 | 905 | 995 | – | 905 | 950 | – | |
| 4 | 350 | 335 | 310 | 500 | 455 | 445 | |
| 5 | 290 | 295 | 300 | 405 | 415 | 415 | |
| 6 | 210 | 215 | 210 | 240 | 240 | 240 | |
| 7 | 335 | 500 | 300 | 197 | 335 | 184 | |